Cargando…
Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike
Recent efforts have focused on immunoadjuvant therapies for sepsis. The host inflammatory response consequent to initial exposure to pathogens is often followed by anti‐inflammatory forces, resulting in increased morbidity and mortality in such critically ill patients. In the subacute stage of sepsi...
Autores principales: | Watanabe, Eizo, Thampy, Lukose K., Hotchkiss, Richard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167396/ https://www.ncbi.nlm.nih.gov/pubmed/30338075 http://dx.doi.org/10.1002/ams2.363 |
Ejemplares similares
-
A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?
por: Katayama, Erryk S., et al.
Publicado: (2020) -
BTLA as a biomarker and mediator of sepsis-induced immunosuppression
por: Sherwood, Edward R, et al.
Publicado: (2013) -
Multiple Functions of Phosphoinositide-3 Kinase Enhancer (PIKE)
por: Chan, Chi Bun, et al.
Publicado: (2010) -
Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration
por: Thampy, Lukose K., et al.
Publicado: (2018) -
Mechanisms of sepsis‐induced immunosuppression and immunological modification therapies for sepsis
por: Ono, Satoshi, et al.
Publicado: (2018)